New medtech startups, identified by name

As I am occasionally known to do, I am providing the list of actual company names recently identified as medtech startups (and included in the Medtech Startups Database).  See below:

  • Tissue Fusion, LLC (laser devices to “weld” biological tissues together for wound closures)
  • Applied Catheter Technologies, Inc. (drug-coated urinary and other catheters and stents that are designed to prevent or treat scar tissue)
  • Cleveland Heart, Inc. (artificial heart technologies)
  • Perfusion Solutions, Inc. (heart pumps)
  • Congruent Medical Technologies, Inc. (compliant balloon technologies)
  • NeoChord, Inc. (device for mitral valve repair without need for sternotomy)
  • Akebia Therapeutics, Inc. (pharmaceutical treatments for ischemia and vascular disease, focused on peripheral artery disease)
  • Svelte Medical Systems, Inc. (non-polymeric drug eluting stent)
  • DiabetiTec LLC (device technology in diabetes management)
  • Loma Vista Medical, Inc. (medical device inflatables, including devices for biological navigation such as in support of colonoscopy and other endoscopy)
  • TransCorp Medical, Inc. (minimally invasive products for motion-preserving spine surgery)
  • Osseon Therapeutics, Inc. (minimally invasive treatment of vertebral compression fractures)
  • Sapheon, Inc. (minimally invasive treatments for removing varicose veins)
  • Lutonix, Inc. (drug-coated angioplasty for coronary and peripheral applications)
  • Carmat SAS (fully implantable artificial heart)

Most of these are pretty darn new, but some have just come out of stealth (whether they realize it or not), since I identified them.

I used to do this more often — giving company name details in forums like this blog — but cut back when I was told I was giving away too much of the store.  However, in the interests of those recently begun following us on Twitter (http://twitter.com/medmarket), I wanted to once again give up a few more of these details.

 

Trackbacks

(Trackback URL)

close Reblog this comment
blog comments powered by Disqus